How AI Is Closing the Early Detection Gap in Liver…
Machine learning models trained on fusion gene biomarkers are outperforming 40 years of conventional AFP testing — and changing what’s…
Blog
Machine learning models trained on fusion gene biomarkers are outperforming 40 years of conventional AFP testing — and changing what’s…
Global liver cancer incidence has risen 75% over the past 20 years. We break down the WHO GLOBOCAN numbers —…
If you have hepatitis, cirrhosis, or NAFLD, your doctor may be relying on ultrasound and AFP — tools that miss…
Our patient support team is available Monday–Saturday, 8am–8pm EST. We’re here to help — no question is too small.
First-in-class blood-based liver cancer early detection. Powered by Fusion-detect™ AI genomics technology.
© 2026 MoleculeDx Inc. All rights reserved.
This test is not a substitute for medical diagnosis. Consult your physician with all results.